An adenoviral-vectored vaccine confers seroprotection against capsular group B meningococcal disease

An adenoviral-vectored vaccine confers seroprotection against capsular group B meningococcal disease

Adenoviral-vectored vaccines are licensed for prevention of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and Ebola virus, but, for bacterial proteins, expression in a eukaryotic cell may affect the antigen's localization and conformation or lead to unwanted glycosylation. Here,...

書誌詳細
主要な著者:	Dold, C, Marsay, L, Wang, N, Silva-Reyes, L, Clutterbuck, E, Paterson, GK, Sharkey, K, Wyllie, D, Beernink, PT, Hill, AV, Pollard, AJ, Rollier, CS
フォーマット:	Journal article
言語:	English
出版事項:	American Association for the Advancement of Science 2023

類似資料

The capsular group B meningococcal vaccine, 4CMenB : clinical experience and potential efficacy.
著者:: Rollier, C, 等
出版事項: (2014)

Viral vectors expressing group B meningococcal outer membrane proteins induce strong antibody responses but fail to induce functional bactericidal activity
著者:: Marsay, L, 等
出版事項: (2022)

Long-term seroprotection after an adolescent booster meningococcal serogroup C vaccination
著者:: De Whalley, P, 等
出版事項: (2013)

Long-term seroprotection after an adolescent booster meningococcal serogroup C vaccination.
著者:: de Whalley, P, 等
出版事項: (2013)

Seroprotection against serogroup C meningococcal disease in adolescents in the United Kingdom: observational study.
著者:: Snape, MD, 等
出版事項: (2008)

Seroprotection against serogroup C meningococcal disease in adolescents in the United Kingdom: observational study
著者:: Snape, M, 等
出版事項: (2008)

Distinct patterns of whole blood transcriptional responses are induced in mice following immunisation with adenoviral and poxviral vector vaccines encoding the same antigen
著者:: Sheerin, D, 等
出版事項: (2021)

Comparative transcriptomics between species attributes reactogenicity pathways induced by the capsular group B meningococcal vaccine, 4CMenB, to the membrane-bound endotoxin of its outer membrane vesicle component.
著者:: Sheerin, D, 等
出版事項: (2019)

Inclusion of a dual signal sequence enhances the immunogenicity of a novel viral vectored vaccine against the capsular group B meningococcus
著者:: Sheerin, D, 等
出版事項: (2022)

Human B cell responses to dominant and sub-dominant antigens induced by a meningococcal outer membrane vesicle vaccine in a phase I trial
著者:: Rollier, CS, 等
出版事項: (2022)

Effect of complement Factor H on antibody repertoire and protection elicited by meningococcal capsular group B vaccines containing Factor H binding protein
著者:: Peter T. Beernink
出版事項: (2020-03-01)

Immunogenicity profiling of protein antigens from capsular group B Neisseria meningitidis
著者:: Awanye, A, 等
出版事項: (2019)

Four component meningococcal capsular Group B vaccine in preterm infants.
著者:: Sadarangani, M, 等
出版事項: (2017)

Alternative vaccine administration by powder injection: Needle-free dermal delivery of the glycoconjugate meningococcal group Y vaccine
著者:: Weissmueller, N, 等
出版事項: (2017)

Distinct patterns of whole blood transcriptional responses are induced in mice following immunisation with adenoviral and poxviral vector vaccines encoding the same antigen
著者:: Dylan Sheerin, 等
出版事項: (2021-10-01)

CRM197-conjugated serogroup C meningococcal capsular polysaccharide, but not the native polysaccharide, induces persistent antigen-specific memory B cells.
著者:: Kelly, D, 等
出版事項: (2006)

Meningococcal vaccine. From capsular polysaccharides of microbes to proteases
著者:: A P Alliluyev, 等
出版事項: (2012-12-01)

Seroprotection against tetanus in southern Vietnam
著者:: Thwaites, CL, 等
出版事項: (2023)

Application of a Neisseria meningitidis antigen microarray to identify candidate vaccine proteins from a human Phase I clinical trial
著者:: Chang, C-M, 等
出版事項: (2022)

Immunogenicity and reactogenicity of a reduced schedule of a 4-component capsular group B meningococcal vaccine: a randomized controlled trial in infants
著者:: Valente Pinto, M, 等
出版事項: (2020)

Inclusion of a dual signal sequence enhances the immunogenicity of a novel viral vectored vaccine against the capsular group B meningococcus
著者:: Dylan Sheerin, 等
出版事項: (2022-06-01)

Erratum: CRM197-conjugated serogroup C meningococcal capsular polysaccharide, but not the native polysaccharide, induces persistent antigen-specific memory B cells (Blood (2006) 108 (2642-2647))
著者:: Kelly, 等
出版事項: (2007)

Anti-Factor H Antibody Reactivity in Young Adults Vaccinated with a Meningococcal Serogroup B Vaccine Containing Factor H Binding Protein
著者:: Kelsey Sharkey, 等
出版事項: (2019-08-01)

Alternative vaccine administration by powder injection: Needle-free dermal delivery of the glycoconjugate meningococcal group Y vaccine.
著者:: Nikolas T Weissmueller, 等
出版事項: (2017-01-01)

A novel meningococcal outer membrane vesicle vaccine with constitutive expression of FetA: A phase I clinical trial.
著者:: Marsay, L, 等
出版事項: (2015)

Factors affecting on hepatitis B seroprotection in hemodialysis patients
著者:: Majid Malaki
出版事項: (2017-01-01)

Natural immunity against capsular group X N. meningitidis following an outbreak in Togo, 2007
著者:: Norheim, G, 等
出版事項: (2018)

Gene expression profiling reveals insights into infant immunological and febrile responses to group B meningococcal vaccine
著者:: O'Connor, D, 等
出版事項: (2020)

Impact of reducing complement inhibitor binding on the immunogenicity of native neisseria meningitidis outer membrane vesicles
著者:: Daniels-Treffandier, H, 等
出版事項: (2016)

Invasive Meningococcal Capsular Group Y Disease, England and Wales, 2007–2009
著者:: Shamez N. Ladhani, 等
出版事項: (2012-01-01)

Long-term thermostabilization of live poxviral and adenoviral vaccine vectors at supraphysiological temperatures in carbohydrate glass.
著者:: Alcock, R, 等
出版事項: (2010)

Different Long-Term Duration of Seroprotection against <i>Neisseria meningitidis</i> in Adolescents and Middle-Aged Adults after a Single Meningococcal ACWY Conjugate Vaccination in The Netherlands
著者:: Milou Ohm, 等
出版事項: (2020-10-01)

Molecular characterization of two sub-family specific monoclonal antibodies to meningococcal Factor H binding protein
著者:: C. Lo Passo, 等
出版事項: (2018-04-01)

Tetanus seroprotection among children in the Democratic Republic of the Congo, 2013-2014.
著者:: Alvan Cheng, 等
出版事項: (2022-01-01)

HBV Seroprotection and Anamnestic Response to Booster Vaccination in Pediatric Cancer Survivors
著者:: Detchvijitr Suwanpakdee MD, 等
出版事項: (2021-07-01)

Persistence of immunity after vaccination with a capsular group B meningococcal vaccine in 3 different toddler schedules
著者:: Sadarangani, M, 等
出版事項: (2017)

Meningococcal disease
著者:: Pollard, A
出版事項: (2018)

Recent advances in lipopolysaccharide-based glycoconjugate vaccines
著者:: Zhu, H, 等
出版事項: (2021)

Meningococcal vaccines.
著者:: Rüggeberg, J, 等
出版事項: (2004)

Meningococcal vaccines.
著者:: Collins, C, 等
出版事項: (2002)